Aflac Inc. (AFL) What most consumers don’t realize is that 80% of Aflac’s business comes from Japan, where it is the number one life insurance company. In the U.S., Aflac is the number one provider of voluntary worksite insurance, and its policies pay cash benefits directly to the insured. One of my favorite things about Aflac as an investment is that the company has one of the best records of dividend increases I have ever come across, with 29 consecutive years of increases.
AFLAC last released its earnings data on Tuesday, October 23rd. The company reported $1.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.11. The company’s revenue for the quarter was up 14.4% on a year-over-year basis. AFLAC has set its Q4 guidance at $1.46-1.51 EPS. Analysts expect that AFLAC will post $6.61 EPS for the current fiscal year.
Currently yielding $1.40 annually, or 2.68%, it is a fairly safe assumption that the increases will continue going forward. Also worth noting is that Aflac trades at only 8.2 times 2012 earnings, which are expected to grow considerably going forward. Consensus estimates call for earnings of $6.92 and $7.38 in 2013 and 2014, respectively. Conservatively assuming the P/E ratio gravitates toward the historic average of around 9 times earnings, this gives us one and two year price targets of $62.28 and $66.42.
AFLAC Stock rating by analyst
AFLAC (NYSE: AFL) was downgraded by equities researchers at JPMorgan Chase from an “overweight” rating to a “neutral” rating in a report issued on Thursday. They currently have a $54.00 target price on the stock, down from their previous target price of $55.00. The analysts noted that the move was a valuation call.
A number of other analysts have also recently weighed in on AFL. Analysts at Barclays Capital reiterated an “overweight” rating on shares of AFLAC in a research note to investors on Thursday. They now have a $65.00 price target on the stock, up previously from $58.00. Separately, analysts at FBR Capital reiterated a “market perform” rating on shares of AFLAC in a research note to investors on Monday. They now have a $52.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of AFLAC in a research note to investors on Monday, December 24th. They now have a $57.00 price target on the stock.
Aflac (NYSE:AFL) has been reiterated by TheStreet Ratings as a buy with a ratings score of B+ . The company’s strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins.
Despite its growing revenue, the company underperformed as compared with the industry average of 21.6%. Since the same quarter one year prior, revenues rose by 14.3%. Growth in the company’s revenue appears to have helped boost the earnings per share.
AFL’s debt-to-equity ratio is very low at 0.28 and is currently below that of the industry average, implying that there has been very successful management of debt levels.
The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. In comparison to the other companies in the Insurance industry and the overall market, AFLAC INC’s return on equity significantly exceeds that of the industry average and is above that of the S&P 500.
Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance. Aflac has a market cap of $25.36 billion and is part of the financial sector and insurance industry. The company has a P/E ratio of 8.9, below the S&P 500 P/E ratio of 17.7. Shares are up 25% year to date as of the close of trading on Tuesday.
Figure Aflac stock chart 1 year
AFLAC Inc.earning growth forecast
AFLAC Inc. (AFL): Provides supplemental health and life insurance. Market cap at $24.86B, most recent closing price at $53.01. Diluted TTM earnings per share at 6.07, and a MRQ book value per share value at 34.1, implies a Graham Number fair value = sqrt(22.5*6.07*34.1) = $68.24. Based on the stock’s price at $53.23, this implies a potential upside of 28.21% from current levels. PEG at 0.88.
Over the next five years, the analysts that follow this company are expecting it to grow earnings at an average annual rate of 10.65%.This year, analysts are forecasting earnings increase of 4.36% over last year. Analysts expect earnings growth next year of 4.42% over this year’s forecasted earnings.
Aflac Inc Business Summary
Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance. The company offers various voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan. It also provides loss-of-income products, such as life and short-term disability plans; and products designed to protect individuals from depletion of assets, which comprise hospital indemnity, fixed-benefit dental, vision care, accident, cancer, critical illness/critical care, and hospital intensive care plans in the United States. The company sells its products through sales associates and brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
Aflac life insurance market outlook 2013, Aflac life insurance plans 2013, Aflac shares prices forecast 2013, Aflac earning estimates 2013, Aflac earning growth 2013, Aflac stock rating 2013, Aflac shares prices target 2013